InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

- Current share price for FRE : $0.030

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 New Product - Nasodine Sinus Rinse 21 Oct 2026 8:32AM $0.028 $0.030 risen by 7.14%
$9 Change in substantial holding - Pharma Nutria 20 Oct 2026 2:54PM $0.028 $0.030 risen by 7.14%
$9 Cleansing Notice 19 Oct 2026 8:37AM $0.033 $0.030 fallen by 9.09%
$9 Application for quotation of securities - FRE 19 Oct 2026 8:34AM $0.033 $0.030 fallen by 9.09%
$9 Nasodine Nasal Spray Approved in the Philippines 16 Oct 2026 8:24AM $0.030 $0.030 fallen by 0%
$9 Notice of AGM & Proxy Form & Letter to Shareholders 12 Oct 2026 2:35PM $0.031 $0.030 fallen by 3.23%
$9 Proposed issue of securities - FRE 12 Oct 2026 8:36AM $0.029 $0.030 risen by 3.45%
$9 Firebrick Secures $732k in Strategic Investments 12 Oct 2026 8:32AM $0.029 $0.030 risen by 3.45%
$9 Firebrick Investor Update Presentation 7 Oct 2026 8:28AM $0.028 $0.030 risen by 7.14%
$9 Firebrick announces USA Retail Launch Plan 29 Sep 2026 8:13AM $0.026 $0.030 risen by 15.38%
$9 Firebrick receives $293,000 R&D Tax Incentive 23 Sep 2026 8:18AM $0.027 $0.030 risen by 11.11%
$9 Notice of AGM and Closing Date for Director Nominations 15 Sep 2026 8:17AM $0.030 $0.030 fallen by 0%
$9 Appendix 4G 31 Aug 2026 5:24PM $0.035 $0.030 fallen by 14.29%
$9 Corporate Governance Statement 31 Aug 2026 5:23PM $0.035 $0.030 fallen by 14.29%
$9 Appendix 4E and Annual Report 30 June 2026 31 Aug 2026 5:23PM $0.035 $0.030 fallen by 14.29%
$9 Cleansing Notice 11 Aug 2026 8:21AM $0.033 $0.030 fallen by 9.09%
$9 Application for quotation of securities - FRE 11 Aug 2026 8:20AM $0.033 $0.030 fallen by 9.09%
$9 Proposed issue of securities - FRE 10 Aug 2026 8:41AM $0.026 $0.030 risen by 15.38%
$9 Update - Notification regarding unquoted securities - FRE 27 Jul 2026 3:26PM $0.027 $0.030 risen by 11.11%
$9 Investor Update 27 Jul 2026 9:33AM $0.028 $0.030 risen by 7.14%
$9 June 2026 Quarterly Activity Report 27 Jul 2026 9:32AM $0.028 $0.030 risen by 7.14%
$9 Change of Address 14 Jul 2026 12:00PM $0.030 $0.030 fallen by 0%
$9 Results of General Meeting 22 Jun 2026 11:21AM $0.036 $0.030 fallen by 16.67%
$9 Nasodine Composition Patent Granted in New Zealand 3 Jun 2026 8:20AM $0.042 $0.030 fallen by 28.57%
$9 Cleansing Notice 2 Jun 2026 8:31AM $0.045 $0.030 fallen by 33.33%

1 - 25 of 522 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.